Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Glioblastoma multiforme (GBM) is an aggressive intracranial tumor characterized by local and distant brain relapse despite aggressive therapy. Current standard treatment includes surgical resection followed by radiation with concurrent and adjuvant temozolomide as part of a combined modality approach. In this review, the historical basis for the current standard treatment is discussed as well as other recent combined modality successes and failures. An overview of emerging combined modality therapies for GBM is presented including immunotherapy, and rationally designed radiosensitizers. Unanswered questions facing the oncology community regarding the treatment of GBM are also discussed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.semradonc.2016.06.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A novel multimodal framework combining habitat radiomics, deep learning, and conventional radiomics for predicting MGMT gene promoter methylation in Glioma: Superior performance of integrated models.
Eur J Radiol
September 2025
Department of Radiology, Affiliated Hospital of Hebei University, Baoding 071000, China. Electronic address:
Purpose: The present study aimed to develop a noninvasive predictive framework that integrates clinical data, conventional radiomics, habitat imaging, and deep learning for the preoperative stratification of MGMT gene promoter methylation in glioma.
Materials And Methods: This retrospective study included 410 patients from the University of California, San Francisco, USA, and 102 patients from our hospital. Seven models were constructed using preoperative contrast-enhanced T1-weighted MRI with gadobenate dimeglumine as the contrast agent.
Extracorporeal blood purification (EBP) is an emerging technique for reducing elevated levels of inflammatory mediators and/or endotoxins in critically ill patients with sepsis or other hyperinflammatory conditions. The oXiris filter combines endotoxin adsorption, cytokine adsorption, hemofiltration and anti-thrombosis, and an emerging body of evidence demonstrates its use in critical care patients with hyperinflammatory conditions and acute kidney injury (AKI). A group of Asia-Pacific experts convened to formulate consensus statements for the use of the oXiris filter based on a comprehensive review of publications.
View Article and Find Full Text PDFEustachian tube dysfunction in obstructive sleep apnea patients: implications for a multimodal treatment approach. A systematic review.
Sleep Breath
September 2025
School of medicine, Università Campus Bio-Medico di Roma, Rome, Italy.
Introduction: It is well known that Obstructive Sleep Apnea (OSA) is a complex disease characterized by an Upper Airway (UA) collapse during sleep, with potential consequences on ENT districts. Recent evidence suggests a possible association with Eustachian Tube Dysfunction (ETD). However, the potential effects of both surgical and non-surgical therapeutic strategies on ET function remain poorly explored in the current literature.
View Article and Find Full Text PDFThe evaluation of non-contrast MRA using a modified balanced steady state free precession technique in the follow-up of renal artery aneurysm after embolotherapy.
Abdom Radiol (NY)
September 2025
Peking University First Hospital, Beijing, China.
Purpose: To evaluate the feasibility and clinical utility of non-contrast magnetic resonance angiography (NC-MRA) using a modified balanced steady-state free precession (b-SSFP) technique combined with arterial spin labeling (ASL) for post-embolotherapy follow-up of renal artery aneurysms (RAAs), with digital subtraction angiography (DSA) as the reference standard.
Method: A total of 57 patients with RAAs underwent embolotherapy between June 2013 and July 2024. Among them, 15 RAAs from 14 patients underwent post-embolization surveillance with the NC-MRA and DSA.
Clinical trial landscape of diabetic retinopathy: global advancements and future directions.
Int J Surg
September 2025
Department of Ophthalmology, The First Affiliated Hospital of Dalian Medical University.
Diabetic retinopathy (DR) remains a leading cause of preventable blindness worldwide, with the affected population projected to reach 270 million by 2045. Our study analyzed 2 434 interventional trials registered between 2007 and 2024 in the Informa Pharma Intelligence database and found that anti-VEGF agents dominate the therapeutic landscape-bevacizumab represents 24.0 % of studies, ranibizumab 15.
View Article and Find Full Text PDF